These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 9737384)

  • 1. Human diploid cell strains (HDCS) viral vaccines.
    Fletcher MA; Hessel L; Plotkin SA
    Dev Biol Stand; 1998; 93():97-107. PubMed ID: 9737384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative analysis of the complete nucleotide sequences of measles, mumps, and rubella strain genomes contained in Priorix-Tetra and ProQuad live attenuated combined vaccines.
    Tillieux SL; Halsey WS; Sathe GM; Vassilev V
    Vaccine; 2009 Apr; 27(16):2265-73. PubMed ID: 19428841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of diploid cell lines as a multiplication substrate for viral vaccine production].
    Welke G
    Z Gesamte Hyg; 1980; 26(5):365-72. PubMed ID: 7008390
    [No Abstract]   [Full Text] [Related]  

  • 5. Vero cell platform in vaccine production: moving towards cell culture-based viral vaccines.
    Barrett PN; Mundt W; Kistner O; Howard MK
    Expert Rev Vaccines; 2009 May; 8(5):607-18. PubMed ID: 19397417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical experience with vaccines produced in the human diploid cell line WI-38.
    Andzaparidze OG
    Natl Cancer Inst Monogr; 1968 Dec; 29():477-84. PubMed ID: 4976367
    [No Abstract]   [Full Text] [Related]  

  • 7. Nonhuman primate diploid cells for vaccine production.
    Petricciani JC
    Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
    Wu JJ; Huang DB; Pang KR; Tyring SK
    J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model.
    Zerboni L; Hinchliffe S; Sommer MH; Ito H; Besser J; Stamatis S; Cheng J; Distefano D; Kraiouchkine N; Shaw A; Arvin AM
    Virology; 2005 Feb; 332(1):337-46. PubMed ID: 15661165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strains of measles vaccine differ in their ability to replicate in an damage human thymus.
    Valsamakis A; Kaneshima H; Griffin DE
    J Infect Dis; 2001 Feb; 183(3):498-502. PubMed ID: 11133383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccines produced in diploid cell lines--discussion.
    Perkins FT
    Natl Cancer Inst Monogr; 1968 Dec; 29():495-7. PubMed ID: 5720803
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of vaccines, interferons and cell substrates for pestivirus contamination.
    Audet SA; Crim RL; Beeler J
    Biologicals; 2000 Mar; 28(1):41-6. PubMed ID: 10799055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and viral propagation properties of a new human diploid cell line, Walvax-2, and its suitability as a candidate cell substrate for vaccine production.
    Ma B; He LF; Zhang YL; Chen M; Wang LL; Yang HW; Yan T; Sun MX; Zheng CY
    Hum Vaccin Immunother; 2015; 11(4):998-1009. PubMed ID: 25803132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoplastic properties of animal cell lines--general comments.
    Macpherson I
    Natl Cancer Inst Monogr; 1968 Dec; 29():295-6. PubMed ID: 4976360
    [No Abstract]   [Full Text] [Related]  

  • 16. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines and viral antigenic diversity.
    Mumford JA
    Rev Sci Tech; 2007 Apr; 26(1):69-90. PubMed ID: 17633294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mumps vaccine virus strains and aseptic meningitis.
    Bonnet MC; Dutta A; Weinberger C; Plotkin SA
    Vaccine; 2006 Nov; 24(49-50):7037-45. PubMed ID: 16884835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology of production of primary and diploid cell cultures.
    Brackett RG
    Natl Cancer Inst Monogr; 1968 Dec; 29():33-4. PubMed ID: 5720801
    [No Abstract]   [Full Text] [Related]  

  • 20. Experience with the Vero cell line.
    Montagnon BJ; Vincent-Falquet JC
    Dev Biol Stand; 1998; 93():119-23. PubMed ID: 9737386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.